A Real-Time Annexin V Method for Monitoring Programmed Cell Death
Poster Nov 28, 2017
Kevin Kupcho, Andrew Niles, John Shultz, Jamison Grailer, Wenhui Zhou, Robin Hurst, Jim Hartnett, Terry Riss, Dan Lazar, and James Cali
We developed a homogeneous luminogenic annexin V binding assay to detect the occurrence of apoptosis in real time using a multimode plate reader. The detection reagent has two different annexin V fusion proteins engineered to contain complementing domains of a binary luciferase, a substrate for luciferase and a cell impermeable fluorogenic DNA dye to detect necrotic cells. The annexin-luciferase fragment fusion pairs have only modest affinity for each other, thus luminescence remains low in the presence of viable cells. When annexin V in the fusion proteins binds in close proximity to the phosphatidylserine exposed on the surface of apoptotic cells, the luciferase fragments reconstitute to form an active enzyme and generate luminescence. The reagent is added directly to cells in culture providing a homogeneous protocol that does not require cell washing steps typically needed with fluorescent annexin V binding assays used for flow cytometry. The real time method has been used to monitor the kinetics of apoptosis and secondary necrosis in several model systems by repeatedly recording luminescence and fluorescence from the same samples of cells.
We found a distinct subpopulation of Tregs within BMSCs. Tregs and BMSCs in co-culture conferred neuroprotection that varied in a dose-dependent manner. Tregs minimized stem cell production of IL-6, a pro-inflammatory cytokine, and inhibited BMSC secretion of FGF-beta, a cytokine related to BMSC proliferation and differentiation. The ratio of Tregs found natively in BMSCs is optimally adapted to provide the maximum neuroprotective benefit of stem cell treatment after ischemic stroke.READ MORE
Patients with partial deficiency of recombination-activating genes 1 or 2 (RAG1/2) can present with a wide spectrum of primary immunodeficiencies including combined immunodeficiency with granuloma and/or autoimmunity (CID-G/AI). Prior case reports have highlighted alterations in B and T cell compartments; however comprehensive characterization of these cell populations with focus on autoreactive-prone subsets has not been reported.READ MORE